Active ingredientOprozomibCat. No. P-O026-001CAS 935888-69-0Family · Pharmaceutical analytical standards
Oprozomib
A second-generation proteasome inhibitor, a close relative of carfilzomib but active by mouth: described in 2009, it was studied in multiple myeloma and Waldenström's macroglobulinaemia and has remained an investigational drug. This family brings together the active ingredient and labelled standards.
Did you know?It belongs to the epoxyketones, a family descending from epoxomicin, an antitumour compound of microbial origin discovered in 1992, from which carfilzomib is also derived.
Go to the active ingredient →Active ingredientOprozomibCat. No. P-O026-001CAS 935888-69-0
Isotopically labelledOprozomib-d6Cat. No. P-O026-002No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.